Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Pays » - entrée « Inde »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hongrie < Inde < Indonésie  Facettes :

List of bibliographic references indexed by Inde

Number of relevant bibliographic references: 256.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000008 (2021) Sandip Mukhopadhyay [Inde] ; Suhrita Paul [Inde] ; Basabdatta Samanta [Inde]Hydroxychloroquine in the prophylaxis of COVID 19: A survey of safety on the healthcare workers in India.
000012 (2021) Sourabh Agstam [Inde] ; Ashutosh Yadav [Inde] ; Praveen Kumar-M [Inde] ; Ankur Gupta [Inde]Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis.
000013 (2021) Sujeet Jha [Inde] ; Nitish Batra [Inde] ; Samreen Siddiqui [Inde] ; Ashutosh Yadav [Inde] ; Archa Misra [Inde] ; Menka Loomba [Inde] ; Sumeet Sethi [Inde] ; Swati Waghdhare [Inde]HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers.
000017 (2021) Atiya R. Faruqui [Inde] ; Denis Xavier [Inde] ; Sandhya K. Kamat [Inde] ; Sujith J. Chandy [Inde] ; Bikash Medhi [Inde] ; Raakhi K. Tripathi [Inde] ; Yashashri C. Shetty [Inde] ; John Michael Raj [Inde] ; Sandeep Kaushal [Inde] ; S. Balakrishnan [Inde] ; Shubham Atal [Inde] ; Santanu K. Tripathi [Inde] ; Dinesh K. Badyal [Inde] ; Harihar Dikshit [Inde] ; Sukalyan Saha Roy [Inde] ; Niyati Trivedi [Inde] ; Suparna Chatterjee [Inde] ; Chetna Desai [Inde] ; C D Tripathi [Inde] ; Nirmala N. Rege [Inde] ; Pooja Gupta [Inde] ; R. Raveendran [Inde] ; Rajni Kaul [Inde] ; Nilima A. Kshirsagar [Inde]Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis.
000030 (2021) Rujittika Mungmunpuntipantip [Thaïlande] ; Viroj Wiwanitkit [Inde]Zebra-like bodies in COVID-19, hydroxychloroquine, and acute renal injury.
000040 (2021) Nicholas Kassis [États-Unis] ; Christine Tanaka-Esposito [États-Unis] ; Roy Chung [États-Unis] ; Ankur Kalra [États-Unis] ; Mingyuan Shao [États-Unis] ; Ashish Kumar [Inde] ; Jafar Alzubi [États-Unis] ; Mina K. Chung [États-Unis] ; Umesh N. Khot [États-Unis]Validating and implementing cardiac telemetry for continuous QTc monitoring: A novel approach to increase healthcare personnel safety during the COVID-19 pandemic.
000045 (2021) Mudit Agarwal [Inde] ; Piyush Ranjan [Inde] ; Ankit Mittal [Inde] ; Upendra Baitha [Inde]Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
000052 (2021) Santanu Santra [Inde] ; Santanab Giri [Inde] ; Madhurima Jana [Inde]Unraveling the origin of interactions of hydroxychloroquine with the receptor-binding domain of SARS-CoV-2 in aqueous medium.
000084 (2021) Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis]The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.
000090 (2021) Anirban Hom Choudhuri [Inde] ; Sakshi Duggal [Inde] ; Bhuvna Ahuja [Inde] ; Partha Sarathi Biswas [Inde]The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
000094 (2021) Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde]The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
000115 (2021) Praveen Kumar-M [Inde] ; Ritin Mohindra [Inde] ; Ashish Bhalla [Inde] ; Nusrat Shafiq [Inde] ; Vikas Suri [Inde] ; Deepa Kumari [Inde] ; Avaneesh Kumar Pandey [Inde] ; Ankur Gupta [Inde] ; Parul Chawla Gupta [Inde] ; Amol Patil [Inde] ; Ashish Kumar Kakkar [Inde] ; Samir Malhotra [Inde]System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India.
000116 (2021) Sathishkumar Chidambaram [Inde] ; Mohamed A. El-Sheikh [Arabie saoudite] ; Ahmed H. Alfarhan [Arabie saoudite] ; Surendrakumar Radhakrishnan [Inde] ; Idhayadhulla Akbar [Inde]Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies.
000119 (2021) Waleed Alhazzani [Canada] ; Laura Evans [États-Unis] ; Fayez Alshamsi [Émirats arabes unis] ; Morten Hylander M Ller [Danemark] ; Marlies Ostermann [Royaume-Uni] ; Hallie C. Prescott [États-Unis] ; Yaseen M. Arabi ; Mark Loeb [Canada] ; Michelle Ng Gong [États-Unis] ; Eddy Fan [Canada] ; Simon Oczkowski [Canada] ; Mitchell M. Levy [États-Unis] ; Lennie Derde [Pays-Bas] ; Amy Dzierba [États-Unis] ; Bin Du [République populaire de Chine] ; Flavia Machado [Brésil] ; Hannah Wunsch [Canada] ; Mark Crowther [Canada] ; Maurizio Cecconi [Italie] ; Younsuck Koh [Corée du Sud] ; Lisa Burry [Canada] ; Daniel S. Chertow [États-Unis] ; Wojciech Szczeklik [Pologne] ; Emilie Belley-Cote [Canada] ; Massimiliano Greco [Italie] ; Malgorzata Bala [Pologne] ; Ryan Zarychanski [Canada] ; Jozef Kesecioglu [Pays-Bas] ; Allison Mcgeer [Canada] ; Leonard Mermel [États-Unis] ; Manoj J. Mammen [États-Unis] ; Sheila Nainan Myatra [Inde] ; Amy Arrington [États-Unis] ; Ruth Kleinpell [États-Unis] ; Giuseppe Citerio [Italie] ; Kimberley Lewis [Canada] ; Elizabeth Bridges [États-Unis] ; Ziad A. Memish ; Naomi Hammond [Australie] ; Frederick G. Hayden [États-Unis] ; Muhammed Alshahrani [Arabie saoudite] ; Zainab Al Duhailib [Canada, Arabie saoudite] ; Greg S. Martin [États-Unis] ; Lewis J. Kaplan [États-Unis] ; Craig M. Coopersmith [États-Unis] ; Massimo Antonelli [Italie] ; Andrew Rhodes [Royaume-Uni]Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
000127 (2021) Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar]Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2.
000128 (2021) Deepak Mishra [Inde] ; Radha Raman Maurya [Inde] ; Kamlesh Kumar [Inde] ; Nupur S. Munjal [Inde] ; Vijay Bahadur [Inde] ; Sandeep Sharma [Inde] ; Prashant Singh [Inde] ; Indra Bahadur [Afrique du Sud]Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies.
000129 (2021) Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde]Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies.
000132 (2021) Kanupriya Arora [Inde] ; Prasan Kumar Panda [Oman]Steroid harms if given early in COVID-19 viraemia.
000144 (2021) Rajesh Kulkarni [Inde] ; Uday Rajput [Inde] ; Rahul Dawre [Inde] ; Naresh Sonkawade [Inde] ; Sameer Pawar [Inde] ; Somendra Sonteke [Inde] ; Balaji Varvatte [Inde] ; K C Aathira [Inde] ; Kailas Gadekar [Inde] ; Santosh Varma [Inde] ; Leena Nakate [Inde] ; Anju Kagal [Inde] ; Aarti Kinikar [Inde]Severe Malnutrition and Anemia Are Associated with Severe COVID in Infants.
000146 (2021) Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil KucaSevere Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics.
000153 (2021) Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde]Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i -k "Inde" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i  \
                -Sk "Inde" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Inde
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021